tirzepatide discovery Mechanism of action (MOA) of Tirzepatide: A First-in-class Twincretin for

Reported side effects are rare and typically mild temporary redness or irritation at the application site, usually resolving quickly No documented systemic toxicity in research literature at typical therapeutic doses European Medicines Agency and independent research groups rate it as well-tolerated Compatible with most standard skincare routines when used with appropriate spacing from incompatible actives Contraindications and cautions Known sensitivity or allergy to copper compounds: avoid use Active skin infections or open wounds at the injection site: delay treatment Pregnancy and breastfeeding: insufficient safety data

The Danger of Freezing Tirzepatide Freezing is just as damaging to tirzepatide as excessive heat

It also has a number of negative side effects, which include vision changes, kidney problems, nausea, and vomiting

Up to 40% less

Gastrointestinal symptoms are the most common early side effects, with nausea affecting approximately 44% of patients, vomiting 24%, diarrhea 30%, and constipation 24% during dose escalation according to clinical trials

Zhou M, et al